ZA 66 125 mg (Divalproex sodium (sprinkle) 125 mg)

Pill imprint ZA 66 125 mg has been identified as Divalproex sodium (sprinkle) 125 mg.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; hyperekplexia (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ZA 66 125 mg

Divalproex sodium (sprinkle) 125 mg ZA 66 125 mg
Divalproex sodium (sprinkle)
Imprint:
ZA 66
125 mg
Strength:
125 mg
Color:
Blue & White
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0106
Inactive Ingredients:
FD&C Blue No. 1
hypromelloses
silicon dioxide
triethyl citrate
methacrylic acid
sodium lauryl sulfate
gelatin
magnesium silicate
titanium dioxide
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0313 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)